Cargando…

Increased DNA methylation of SLFN12 in CD4(+) and CD8(+) T cells from multiple sclerosis patients

DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rhead, Brooke, Brorson, Ina S., Berge, Tone, Adams, Cameron, Quach, Hong, Moen, Stine Marit, Berg-Hansen, Pål, Celius, Elisabeth Gulowsen, Sangurdekar, Dipen P., Bronson, Paola G., Lea, Rodney A., Burnard, Sean, Maltby, Vicki E., Scott, Rodney J., Lechner-Scott, Jeannette, Harbo, Hanne F., Bos, Steffan D., Barcellos, Lisa F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209300/ https://www.ncbi.nlm.nih.gov/pubmed/30379917 http://dx.doi.org/10.1371/journal.pone.0206511

Ejemplares similares

No differential gene expression for CD4(+) T cells of MS patients and healthy controls
por: Brorson, Ina S, et al.
Publicado: (2019)

Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015)

Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1
por: Maltby, Vicki E., et al.
Publicado: (2017)

DNA methylation changes in CD4(+) T cells isolated from multiple sclerosis patients on dimethyl fumarate
por: Maltby, Vicki E, et al.
Publicado: (2018)

Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018)

Letter to the editor: blood processing and sample storage have negligible effects on methylation
por: Groen, Kira, et al.
Publicado: (2018)

Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells
por: Leikfoss, Ingvild S., et al.
Publicado: (2015)

Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
por: Sanders, Katherine A., et al.
Publicado: (2016)

Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020)

The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
por: Lycett, Mitchell J, et al.
Publicado: (2023)

Quantitative proteomic analyses of CD4(+) and CD8(+) T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls
por: Berge, Tone, et al.
Publicado: (2019)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

CD8(+) T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls
por: Brorson, IS, et al.
Publicado: (2020)

Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018)

Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis
por: Bos, Steffan D., et al.
Publicado: (2015)

Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models
por: Burnard, Sean M., et al.
Publicado: (2021)

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity
por: Campagna, Maria Pia, et al.
Publicado: (2022)

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2020)

Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response
por: Alvi, Erin, et al.
Publicado: (2023)

Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case–control study
por: Gustavsen, Marte Wendel, et al.
Publicado: (2014)

Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study
por: Moen, Stine Marit, et al.
Publicado: (2012)

The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020)

Epigenome-wide association studies: current knowledge, strategies and recommendations
por: Campagna, Maria Pia, et al.
Publicado: (2021)

Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
por: Simonsen, Cecilia Smith, et al.
Publicado: (2020)

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
por: Simonsen, Cecilia Smith, et al.
Publicado: (2021)

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
por: Campagna, Maria Pia, et al.
Publicado: (2023)

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
por: Berge, T, et al.
Publicado: (2016)

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
por: Maltby, Vicki, et al.
Publicado: (2023)

Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase
por: Garvie, Colin W., et al.
Publicado: (2021)

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes
por: Xavier, Alexandre, et al.
Publicado: (2023)

Mechanistic understanding of human SLFN11
por: Metzner, Felix J., et al.
Publicado: (2022)

The instrumented single leg stance test detects early balance impairment in people with multiple sclerosis
por: Berg-Hansen, Pål, et al.
Publicado: (2023)

Comments on the review article ‘Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades’
por: Berg‐Hansen, P., et al.
Publicado: (2015)

SLFN14 gene mutations associated with bleeding
por: Stapley, Rachel J., et al.
Publicado: (2019)

SLFN11’s surveillance role in protein homeostasis
por: Murai, Yasuhisa, et al.
Publicado: (2022)

Sensor-based gait analyses of the six-minute walk test identify qualitative improvement in gait parameters of people with multiple sclerosis after rehabilitation
por: Berg-Hansen, Pål, et al.
Publicado: (2022)

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
por: Bateman, Grant A., et al.
Publicado: (2016)

Ribosome dysfunction underlies SLFN14-related thrombocytopenia
por: Ver Donck, Fabienne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m4rlnj88g9hjhbmap4nns1bgel